Blood and immune-system disorders
Haematopoietic stem-cell transplantation is established for selected blood and immune disorders, which makes this category fundamentally different from most commercial regenerative uses.
What the registry pattern says
Anemia has the largest MSC registry footprint in this group (0 query results; 0 recruiting in the stored snapshot). Anemia has the largest exosome footprint (0). These are query-result counts, not deduplicated patients or proof of benefit.
Diagnosis, donor matching, conditioning and transplant-centre experience determine the pathway. Do not transfer evidence from an established HSCT indication to a generic MSC infusion.
Condition × therapy-class snapshot
| Condition | MSC | MSC recruiting | HSCT-family | Exosomes |
|---|---|---|---|---|
| Anemia | 0 | 0 | 0 | 0 |
| Primary immunodeficiency | 0 | 0 | 0 | 0 |
Source: ClinicalTrials.gov API v2 stored snapshot. Category totals add query results and may contain overlapping studies; use condition pages for interpretation.
Interactive/editorial page by the StemCellAtlas research team. Where registry or literature counts appear, they use the dated 2026-08-29 snapshot. Browser-only tools do not send or store answers. Page generated 2026-08-29. See our editorial standards.